ETHZilla Corporation (ETHZ) Stock Analysis

ETHZilla Corporation (ETHZ) is a publicly traded company in the HEALTHCARE sector. It trades at $4.57. This page summarizes the public market data, fundamentals, and frequently asked questions for ETHZ, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.57

Market Sentiment

ETHZilla Corporation currently has a Neutral sentiment score of 0.09.

About ETHZilla Corporation

ETHZilla Corporation is a clinical-stage biotechnology firm based in Palm Beach, Florida, focused on developing innovative therapeutics for chronic pain, inflammation, fibrosis, and various inflammatory diseases. The company is dedicated to addressing significant unmet medical needs through its advanced pipeline of novel drug candidates, which promise to enhance patient outcomes in underserved therapeutic areas. With a strong commitment to research and development, ETHZilla aims to leverage c...

GNG Research Analysis

GNG Research scores ETHZilla Corporation (ETHZ) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ETHZ.

Frequently Asked Questions

Does ETHZ pay dividends?

ETHZilla Corporation (ETHZ) does not currently pay a regular dividend.